Insulin Patients Impacted By Drug-Pricing Scheme, Court Told
A class of diabetes patients alleging the three top insulin manufacturers colluded to drive up medicine prices for the uninsured and underinsured told a New Jersey federal judge Thursday they have...To view the full article, register now.
Already a subscriber? Click here to view full article